Ignition of Small Molecule Inhibitors in Friedreich's Ataxia with Explainable Artificial Intelligence
Iron (Fe) chelating medicines and Histone deacetylase (HDAC) inhibitors are two therapy options for hereditary Friedreich's Ataxia that have been shown to improve clinical results (FA). Fe chelation molecules can minimize the quantity of stored Fe, and HDAC inhibitors can boost the expression o...
Main Authors: | Kevser Kübra Kirboğa, Ecir Uğur Küçüksille, Utku Kose |
---|---|
Format: | Article |
Language: | English |
Published: |
EduSoft publishing
2023-10-01
|
Series: | Brain: Broad Research in Artificial Intelligence and Neuroscience |
Subjects: | |
Online Access: | https://www.edusoft.ro/brain/index.php/brain/article/view/1427 |
Similar Items
-
Anesthetic Management on a Patient with Friedreichs Ataxia
by: Ulku Ozgul, et al.
Published: (2013-12-01) -
Respiratory Function in Friedreich’s Ataxia
by: Elena Vinante, et al.
Published: (2022-08-01) -
Diagnostic Delay and Clinical Features in Friedreich’s Ataxia
by: Mehmet Fatih Yetkin, et al.
Published: (2022-06-01) -
Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
by: Vilema Enriquez, MG
Published: (2018) -
Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01)